Home/Filings/4/0001062993-21-000140
4//SEC Filing

HARDY REGINALD L 4

Accession 0001062993-21-000140

CIK 0000819050other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 6:33 PM ET

Size

9.8 KB

Accession

0001062993-21-000140

Insider Transaction Report

Form 4
Period: 2020-12-31
HARDY REGINALD L
DirectorChairman of the Board
Transactions
  • Tax Payment

    Common Stock

    2020-12-31$0.78/sh4,873$3,801200,976 total
  • Award

    Common Stock

    2021-01-01$0.78/sh+47,435$36,999248,411 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    21,826
  • Common Stock

    (indirect: By Trust)
    17,260
  • Common Stock

    (indirect: By Self as General Partner)
    266,447
  • Common Stock

    (indirect: By Spouse)
    9,261
  • Common Stock

    (indirect: By Trust)
    17,260
Footnotes (2)
  • [F1]Represents shares withheld to satisfy tax withholding obligations upon the vesting of RSUs.
  • [F2]On January 1, 2021, the reporting person was granted 47,435 RSUs in lieu of a portion of cash compensation as a director of Brickell Biotech, Inc. The RSUs are scheduled to vest on December 31, 2021 and will be settled in the form of one share of common stock for each RSU.

Issuer

Brickell Biotech, Inc.

CIK 0000819050

Entity typeother

Related Parties

1
  • filerCIK 0001008105

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 6:33 PM ET
Size
9.8 KB